I just closed my blog’s poll on what are the most clinically promising pluripotent stem cells.
Why close the poll now less than 12 hours after I opened it instead of leaving the poll open longer?
You’ll find out soon enough. I can’t resist teasing you readers sometimes.
iPS cells were the big winners in the poll at 48%.
Allogeneic human ES cells were 2nd at 28%. In contrast, not a single person voted for SCNT-derived human ES cells.
Adult pluripotent stem cells finished 3rd at 20%. I found this surprising.
4% said “other”….not sure what “other” pluripotent stem cells exist.
I predict if (when) I repeat this poll soon, we’ll see a very different picture.
I find your polling results interesting, however I noticed that there was no mention of parthenogenetic stem cells mentioned…granted this could be encapsulated under the “other” topic, but as they are a relatively new and unknown field to the “layperson” but I would have thought you would have knowledge of them to include in your poll.
Pingback: Research Uncovers Approach That May Decrease Complications of Stem Cell … – HealthCanal.com | Stem Cell Therapies
Pingback: Penny-Wise, Pound-Foolish Stem Cell Stocks – Seeking Alpha | Stem Cell Therapies